President Yoon Suk Yeol granted pardons to 2,176 people, Monday, on the occasion of Liberation Day (Aug. 15), including the former chiefs of Kumho Petrochemical, Booyoung and Lotte Foundation.
By Baek Byung-yeul, Kim Yoo-chul
Korean biotechnology firm, ST Pharm, is in talks with Moderna to produce messenger RNA (mRNA) COVID-19 vaccines, sources familiar with the matter told The Korea Times, Tuesday. ST Pharm is in talks with Moderna to produce its mRNA vaccines following approval by the Ministry of Food and Drug Safety, one source said on condition of anonymity.
ST Pharm declined to comment on the possibility of signing a contract manufacturing organization (CMO) deal with Moderna. ST Pharm plans to apply liquid nanoparticle (LNP)-based drug substance technology for its RNA vaccines. The government will assist ST Pharm and other local biotech firms in their plans to develop mRNA vaccines, a government official said.